Curium to market xenon-133 gas in the U.S.

By staff writers

May 10, 2018 -- Global nuclear medicine firm Curium has expanded its U.S. offerings to include xenon-133 gas, sourced from its Petten manufacturing facility in the Netherlands and using low-enriched uranium targets.

Xenon-133 gas is useful for diagnostic inhalation studies to evaluate pulmonary function and for lung imaging, and it may also be used to assess cerebral blood flow, the company said.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking